Release 5 Preview #2

This page is part of the FHIR Specification (v4.4.0: R5 Preview #2). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B

Medicinalproductdefinition-example

Biomedical Research and Regulation Work Group

Maturity Level: N/A

Standards Status: Informative

Compartments: Not linked to any defined compartments

This is the narrative for the resource. See also the XML, JSON or Turtle format. This example conforms to the profile MedicinalProductDefinition.

Generated Narrative with Details

id: example

identifier: {mpid}

productClassification: WHOAnatomicalTherapeuticChemicalATCClassificationSystem|B01AF02 (Details : {http://ema.europa.eu/example/WHOAnatomicalTherapeuticChemicalATCClassificationSystem code 'WHOAnatomicalTherapeuticChemicalATCClassificationSystem|B01AF02' = 'WHOAnatomicalTherapeuticChemicalATCClassificationSystem|B01AF02)

attachedDocument: DocumentReference/example

masterFile: DocumentReference/example

name
productName: Equilidem 2.5 mg film-coated tablets
namePart
part: Equilidem
type: INV (Details : {[not stated] code 'INV' = 'INV)
namePart
part: 2.5 mg
type: STR (Details : {[not stated] code 'STR' = 'STR)
namePart
part: film-coated tablets
type: FRM (Details : {[not stated] code 'FRM' = 'FRM)
CountryLanguages
- Country Jurisdiction Language
* EU (Details : {http://ema.europa.eu/example/countryCode code 'EU' = 'EU) EU (Details : {http://ema.europa.eu/example/jurisdictionCode code 'EU' = 'EU) EN (Details : {http://ema.europa.eu/example/languageCode code 'EN' = 'EN)

ManufacturingBusinessOperations

-

Type

EffectiveDate

Authorization

*

2013-03-15 --> (ongoing)

Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.